Banyan Biomarkers Overview
- Year Founded
-
2002
- Status
-
Acquired/Merged
- Employees
-
18
- Latest Deal Type
-
M&A
- Investors
-
1
Banyan Biomarkers General Information
Description
Developer of biomarkers designed to improve outcomes for patients suffering from neurological injuries and diseases. The company's biomarkers aim to rule out the need for CT scans in patients with a suspected mild traumatic brain injury that is based on actual data and not subjective interpretation, enabling physicians to identify and triage patients that need additional medical assistance and benefits by reducing radiation exposure from unnecessary CT scans.
Contact Information
Website
www.banyanbio.comCorporate Office
- 16470 West Bernardo Drive
- Suite 100
- San Diego, CA 92127
- United States
Corporate Office
- 16470 West Bernardo Drive
- Suite 100
- San Diego, CA 92127
- United States
Banyan Biomarkers Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Merger/Acquisition | 01-Dec-2021 | Completed | Generating Revenue | |||
| 8. Later Stage VC | 16-Jun-2020 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series A2) | 06-Feb-2017 | Completed | Generating Revenue | |||
| 6. Grant | 23-Jul-2015 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series A1) | 24-Feb-2014 | Completed | Generating Revenue | |||
| 4. Grant | 30-Jan-2014 | Completed | Generating Revenue | |||
| 3. Grant | 03-Oct-2013 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series A) | 31-Jul-2013 | $6M | $6M | Completed | Generating Revenue | |
| 1. University Spin-Out | 01-Jan-2002 | Completed | Startup |
Banyan Biomarkers Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A2 | ||||||||
| Series A1 | ||||||||
| Series A | 8,823,529 | $0.000100 | 8% | $0.68 | $0.68 | 1x | $0.68 | 16.58% |
Banyan Biomarkers Comparisons
Industry
Financing
Details
Banyan Biomarkers Competitors (8)
One of Banyan Biomarkers’s 8 competitors is AnTolRx, a Formerly VC-backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| AnTolRx | Formerly VC-backed | Cambridge, MA | ||||
| Foundation Medicine | Formerly VC-backed | Boston, MA | ||||
| Kynexis | Venture Capital-Backed | Naarden, Netherlands | ||||
| Cellmade | Private Equity-Backed | Ruffieux, France | ||||
| NanoDx | Venture Capital-Backed | Southborough, MA |
Banyan Biomarkers Patents
Banyan Biomarkers Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3532496-A1 | Antibodies to ubiquitin c-terminal hydrolase l1 (uch-l1) and glial fibrillary acidic protein (gfap) and related methods | Pending | 28-Oct-2016 | ||
| JP-2022166139-A | Antibodies to ubiquitin c-terminal hydrolase l1 (uch-l1) and glial fibrillary acidic protein (gfap) and related methods | Active | 28-Oct-2016 | ||
| JP-2024050716-A | Antibodies to ubiquitin c-terminal hydrolase l1 (uch-l1) and glial fibrillary acidic protein (gfap) and related methods | Active | 28-Oct-2016 | ||
| WO-2018081649-A1 | Antibodies to ubiquitin c-terminal hydrolase l1 (uch-l1) and glial fibrillary acidic protein (gfap) and related methods | Inactive | 28-Oct-2016 | ||
| WO-2015134551-A1 | Micro rna markers for diagnosis of a neurological condition | Inactive | 03-Mar-2014 | C12Q1/6883 |
Banyan Biomarkers Signals
Banyan Biomarkers Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Anzu Partners | Venture Capital | Minority | ||
| GE Aerospace | Corporation | |||
| NFL Pension Plan | Limited Partner | |||
| United States Department of War | Government |
Banyan Biomarkers FAQs
-
When was Banyan Biomarkers founded?
Banyan Biomarkers was founded in 2002.
-
Where is Banyan Biomarkers headquartered?
Banyan Biomarkers is headquartered in San Diego, CA.
-
What is the size of Banyan Biomarkers?
Banyan Biomarkers has 18 total employees.
-
What industry is Banyan Biomarkers in?
Banyan Biomarkers’s primary industry is Biotechnology.
-
Is Banyan Biomarkers a private or public company?
Banyan Biomarkers is a Private company.
-
What is Banyan Biomarkers’s current revenue?
The current revenue for Banyan Biomarkers is .
-
How much funding has Banyan Biomarkers raised over time?
Banyan Biomarkers has raised $23.9M.
-
Who are Banyan Biomarkers’s investors?
Anzu Partners, GE Aerospace, NFL Pension Plan, and United States Department of War have invested in Banyan Biomarkers.
-
Who are Banyan Biomarkers’s competitors?
AnTolRx, Foundation Medicine, Kynexis, Cellmade, and NanoDx are some of the 8 competitors of Banyan Biomarkers.
-
When was Banyan Biomarkers acquired?
Banyan Biomarkers was acquired on 01-Dec-2021.
-
Who acquired Banyan Biomarkers?
Banyan Biomarkers was acquired by BioMérieux.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process